Location History:
- Charenton, FR (2014)
- Paris, FR (2012 - 2022)
- Maisons Alfort, FR (2012 - 2022)
- Maison Alfort, FR (2017 - 2024)
Company Filing History:
9 out of 1,743 
6 out of 5,069 
4 out of 3,923 
Years Active: 2012-2024
Title: **Thierry Leveillard: Innovator in Retinal Degeneration Treatments**
Introduction
Thierry Leveillard, based in Paris, France, is an accomplished inventor known for his significant contributions to the field of retinal degeneration treatments. With a remarkable portfolio of 14 patents, he has dedicated his career to advancing medical solutions for vision-related ailments.
Latest Patents
Leveillard's latest innovations include the invention of transgenic RPE cells which overexpress OTX2 for the treatment of retinal degeneration. This invention focuses on addressing retinal degeneration resulting from dysfunction in the retinal pigment epithelium. Additionally, he has developed methods for expressing a polynucleotide of interest in cone photoreceptors through the subretinal delivery of a therapeutically effective amount of a recombinant AAV9-derived vector. This innovation involves a novel vector-promoter combination to tackle the challenges associated with AAV-mediated cone transduction in the fovea, enabling high-level transgene expression that supports optogenetic vision restoration.
Career Highlights
Thierry Leveillard has had a distinguished career, particularly through his associations with premier research institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His work has been pivotal in evolving strategies to combat retinal diseases, showcasing his expertise and commitment to ophthalmic research.
Collaborations
Throughout his career, Leveillard has collaborated with various esteemed scientists, including his notable coworker, Jose-Alain Sahel. These collaborations have further fueled advancements in retinal research, leading to innovative approaches in treating degenerative eye diseases.
Conclusion
Thierry Leveillard exemplifies the role of an innovator in the medical field, particularly in developing therapeutic solutions for retinal degeneration. His achievements, evidenced by his extensive patent portfolio, reflect his dedication to enhancing the quality of life for individuals affected by vision impairment. The innovations he has contributed to are invaluable in the ongoing pursuit of effective treatments for retinal diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.